Detailed Narrative
Operational Excellence and Technology Investment
BrightSpring continues to invest in and progress on key clinical, HR, and operational systems, leveraging new automation and AI tools in areas such as hiring, onboarding, intake, documentation, medication reviews, and patient care plans. The company has seen almost 300 employees receive Lean Sigma certification, completing Lean projects across the organization to institutionalize lean business processes and drive efficiency.
Strategic Growth Drivers
The company's strategy is aligned with secular trends in U.S. healthcare, focusing on strong execution, thoughtful innovation, and continuous improvement. This includes expanding into adjacent and new markets, executing preferred MA and ACO contracts, and making de novo investments. These efforts, combined with leading quality results, are driving volume growth above industry levels, particularly in Home Health Care.
Specialty and Infusion Business Momentum
The Specialty and Infusion business delivered strong performance with 30% revenue growth and 31% script growth, driven by the branded oncology LDD portfolio. The company is leveraging its capabilities to expand into other targeted therapeutic areas, including rare, orphan, and complex therapies, securing noteworthy partnership wins. In Q2, 2 ultra-narrow network LDDs were added, bringing the total to 155, with 12 LDDs launched year-to-date.
Home and Community Pharmacy Optimization
Despite a revenue impact from the IRA and the strategic exit of certain uneconomic skilled nursing customers, the Home and Community Pharmacy business improved its profitability year-over-year. This was achieved through continued investment in automation and technology to enhance efficiency and service across its scaled national footprint, serving growing end markets like assisted living, behavioral, hospice, and skilled nursing.
Provider Services Integration and Quality
The integration of acquired Amedisys and LHC branches into Home Health has progressed extremely well, particularly in HR and IT, with nearly 95% of branches maintaining 4-star or better ratings. Hospice services continue to demonstrate industry-leading quality metrics and strong census growth, while Rehab Care and Personal Care also show consistent performance and high patient satisfaction scores.
Capital Allocation and M&A Strategy
BrightSpring maintains a full and robust M&A pipeline, focusing on disciplined execution of tuck-in acquisitions and geographical expansions that meet strategic objectives and offer accretive value. The company leverages its scale and operational capabilities to integrate these deals, aiming to increase the frequency of smaller tuck-ins while remaining disciplined on valuations for larger transactions, especially given its improved balance sheet and strong operating cash flow.
Regulatory Environment and Advocacy
CMS released preliminary rates for home health services for calendar year 2027, which include a positive annual payment update, marking the first such upward adjustment in several years. BrightSpring continues to engage with CMS and Congress, advocating for the positive health outcomes and lower Medicare cost profile associated with high-quality home health services.